Emerging Tools and Technologies for Microbiome‐Aware Drug Development

Pharmacomicrobiomics explores the role of the gut microbiota in pharmacokinetics and pharmacodynamics, paving the way for new biomarkers and intervention strategies to reduce interindividual variability in drug response. Emerging mechanistic insights and tools enable microbiome-aware approaches as a promising new facet of personalized medicine.